Department of Surgery

Medicine & Life Sciences

1. Indonesia 100%
2. Prostatic Neoplasms 63%
3. Prostate 41%
4. Percutaneous Nephrolithotomy 29%
5. Systematic Reviews 28%
6. Prostatic Hyperplasia 28%
7. Breast Neoplasms 28%
8. Neoplasms 26%
9. Meta-Analysis 25%
10. Transplants 25%
11. Prostate-Specific Antigen 24%
12. Erectile Dysfunction 24%
13. Therapeutics 23%
14. Kidney 22%
15. Pandemics 21%
16. Wounds and Injuries 21%
17. Urologists 20%
18. Urinary Bladder 20%
19. Nephrectomy 20%
20. Kidney Transplantation 19%
21. Kidney Calculi 19%
22. Living Donors 18%
23. Platelet-Rich Fibrin 18%
24. Diabetic Foot 18%
25. Hypospadias 18%
26. Fistula 17%
27. Cleft Lip 17%
28. Skin 17%
29. Lower Urinary Tract Symptoms 17%
30. Incidence 16%
31. Urology 16%
32. Safety 16%
33. Pediatrics 16%
34. Hyaluronic Acid 16%
35. Hand 15%
36. Honey 15%
37. Cleft Palate 14%
38. Tissue Donors 14%
39. Cadherins 14%
40. Urinary Bladder Neoplasms 14%
41. Survival 13%
42. Urinary Calculi 13%
43. General Hospitals 13%
44. Mortality 13%
45. Ureter 12%
46. Randomized Controlled Trials 12%
47. Overactive Urinary Bladder 12%
48. Tourniquets 12%
49. Neoplasm Metastasis 12%
50. Lithotripsy 12%
51. Stents 12%
52. Urine 12%
53. Surgeons 11%
54. Carcinoma 11%
55. Bone and Bones 11%
56. Biopsy 11%
57. Contracture 11%
58. Prostatectomy 11%
59. Smooth Muscle 11%
60. Wound Healing 11%
61. Thoracic Surgery 11%
62. Intraabdominal Infections 11%
63. Mesenchymal Stem Cells 11%
64. Referral and Consultation 10%
65. Perforator Flap 10%
66. Length of Stay 10%
67. Rabbits 10%
68. Prospective Studies 10%
69. Child 10%
70. Burns 10%
71. Transurethral Resection of Prostate 9%
72. Tetralogy of Fallot 9%
73. Urolithiasis 9%
74. Esthetics 9%
75. Population 9%
76. Drug Therapy 9%
77. Odds Ratio 9%
78. Databases 9%
79. Retrospective Studies 9%
80. Quality of Life 9%
81. Phosphodiesterase Inhibitors 9%
82. Androgens 9%
83. Osteosarcoma 9%
84. PubMed 9%
85. Hemorrhage 9%
86. Liver Transplantation 9%
87. Hyperplasia 9%
88. Cohort Studies 9%
89. Varicocele 9%
90. Coronavirus 9%
91. Transitional Cell Carcinoma 9%
92. Surgical Wound Infection 8%
93. Phosphoric Diester Hydrolases 8%
94. Injections 8%
95. Recurrence 8%
96. Breast 8%
97. Limb Salvage 8%
98. Surgical Flaps 8%
99. Cross-Sectional Studies 8%
100. Guidelines 8%